ViewRay Financial Statements From 2010 to 2024
| VRAYDelisted Stock | USD 0.04 0 5.67% |
Check ViewRay financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among ViewRay's main balance sheet or income statement drivers, such as , as well as many indicators such as . ViewRay financial statements analysis is a perfect complement when working with ViewRay Valuation or Volatility modules.
ViewRay |
ViewRay Company Return On Equity Analysis
ViewRay's Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Current ViewRay Return On Equity | -1.09 |
Most of ViewRay's fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, ViewRay is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
CompetitionBased on the latest financial disclosure, ViewRay has a Return On Equity of -1.0891. This is 95.46% lower than that of the Health Care Equipment & Supplies sector and 87.52% lower than that of the Health Care industry. The return on equity for all United States stocks is notably higher than that of the company.
ViewRay Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining ViewRay's current stock value. Our valuation model uses many indicators to compare ViewRay value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across ViewRay competition to find correlations between indicators driving ViewRay's intrinsic value. More Info.ViewRay is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the ViewRay's earnings, one of the primary drivers of an investment's value.About ViewRay Financial Statements
ViewRay investors use historical fundamental indicators, such as ViewRay's revenue or net income, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in ViewRay. Please read more on our technical analysis and fundamental analysis pages.
ViewRay, Inc. designs, manufactures, and markets magnetic resonance imaging guided radiation therapy systems to image and treat cancer patients in the United States, France, Taiwan, the United Kingdom, and internationally. The company was founded in 2004 and is headquartered in Oakwood, Ohio. Viewray operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 267 people.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.
Other Consideration for investing in ViewRay Stock
If you are still planning to invest in ViewRay check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the ViewRay's history and understand the potential risks before investing.
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios |